Search results
FDA advisers vote against first MDMA therapy to treat PTSD
CNN via Yahoo News· 14 hours agoA federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...
FDA advisers vote against recommending approval of MDMA as treatment for PTSD
ABC News· 15 hours agoA panel of independent advisers for the U.S. Food and Drug Administration voted against recommending...
FDA warns parents about Crecelac infant formula—what parents need to know about the recall
Motherly via Yahoo News· 1 day agod3sign/Getty/FDA The FDA has issued an alert warning parents to avoid buying formula from a Texas...
FDA advisors reject MDMA therapy for PTSD, amid concerns over research
MPR News· 2 hours agoIt represents a major setback for proponents of the drug and its sponsor Lykos Therapeutics, potentially jeopardizing FDA approval of the treatment. Following public comment ...
Psychedelic stocks fall as FDA regulatory advisers fail to back MDMA-based PTSD treatment By...
Investing.com· 37 minutes agoPsychedelic stocks declined Wednesday after advisers to the U.S. Food and Drug Administration failed...
FDA panel rejects first MDMA treatment amid deep concerns about flawed trials
NBC News via Yahoo News· 13 hours agoA Food and Drug Administration advisory panel on Tuesday declined to recommend the approval of MDMA,...
FDA advisory panel votes against allowing MDMA as PTSD treatment
United Press International via Yahoo News· 12 hours agoThe popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an...
FDA advisers vote against first MDMA therapy to treat PTSD
CNN.com· 14 hours agoAfter hearing presentations from the US Food and Drug Administration, treatment sponsor Lykos...
FDA panel rejects psychedelic drug MDMA as a PTSD treatment - The Boston Globe
The Boston Globe· 12 hours agoThe FDA is not required to follow the group’s advice and is expected to make its final decision by...
FDA advisers consider MDMA therapy to treat PTSD
WISN 12 Milwaukee· 23 hours agoA federal advisory committee meets on Tuesday to weigh the risks and benefits of using MDMA, commonly known as ecstasy, as a treatment for post-traumatic...